55 completed, 33 active not recruiting, 24 recruiting, 23 terminated. 86 Phase 2, 52 Phase 1, 31 Phase 3, 5 Not applicable, 3 Early Phase 1.
Follow auricularum: new trials by email Literature Review of auricularum trials Research Report on auricularum
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Testing the Investigational Medication Combination of Daratumumab and Teclistamab Compared to the Usual Treatment (Daratumumab, Pomalidomide, Dexamethasone or Daratumumab, Carfilzomib, Dexamethasone) for Patients With High-risk Multiple Myeloma Refractory or in First Relapse Biospecimen Collection, Bone Marrow Biopsy, Carfilzomib - Recurrent Multiple Myeloma, Refractory Multiple Myeloma | Phase 2 | Recruiting | National Cancer Institute (NCI) | 80 | 2027-05-22 | 2026-10-23 |
| Testing an Experimental Approach to Treat Patients With Plasma Cell Leukemia, The QUANTUM Trial Autologous Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Bone Marrow Aspiration - Plasma Cell Leukemia | Phase 2 | Recruiting | National Cancer Institute (NCI) | 74 | 2027-04-20 | 2026-10-07 |
| Testing the Investigational Medication Combination of Teclistamab and Pomalidomide Compared to the Usual Treatment (Carfilzomib, Pomalidomide, and Dexamethasone) for Patients With Multiple Myeloma Who Have Relapsed Shortly After Treatment Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Multiple Myeloma, Refractory Multiple Myeloma | Phase 1 / Phase 2 | Recruiting | National Cancer Institute (NCI) | 162 | 2027-04-12 | 2026-10-16 |
| FPS-ZM1 With or Without Dexamethasone for Controlling Post Operative Cerebral Edema in Patients With Glioblastoma Biospecimen Collection, Computed Tomography, Dexamethasone - Glioblastoma, Malignant Glioma | Phase 1 | Not yet recruiting | City of Hope Medical Center | 24 | 2027-02-17 | 2026-08-27 |
| Testing the Use of High Dose Testosterone Followed by Darolutamide Compared to the Usual Care for Patients With Metastatic Prostate Cancer Abiraterone Acetate, Biospecimen Collection, Bone Scan - Metastatic Castration-Resistant Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 | Phase 2 / Phase 3 | Not yet recruiting | ECOG-ACRIN Cancer Research Group | 432 | 2027-01-06 | 2026-10-01 |
| Testing the Addition of an Anti-Cancer Drug, Glofitamab, to the Usual Chemotherapy Treatment (Alternating R-CHOP/R-DHAP) for Previously Untreated Mantle Cell Lymphoma Biospecimen Collection, Cisplatin, Computed Tomography - Ann Arbor Stage II Mantle Cell Lymphoma, Ann Arbor Stage III Mantle Cell Lymphoma | Phase 1 | Not yet recruiting | National Cancer Institute (NCI) | 16 | 2026-10-30 | 2026-09-03 |
| Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute Lymphoblastic Leukemia With a Genetic Change Requiring More Treatment Biospecimen Collection, Blinatumomab, Bone Marrow Aspiration - Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia | Phase 2 | Not yet recruiting | SWOG Cancer Research Network | 90 | 2026-10-14 | 2026-10-13 |
| Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL) Biopsy Procedure, Biospecimen Collection, Bone Marrow Aspiration - Stage II T Lymphoblastic Leukemia/Lymphoma, Stage III T Lymphoblastic Leukemia/Lymphoma | Phase 2 / Phase 3 | Not yet recruiting | Children's Oncology Group | 1708 | 2026-08-28 | 2026-07-30 |
| Selvigaltin With Standard of Care Treatment for the Treatment of Relapsed/Refractory Multiple Myeloma Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Multiple Myeloma, Refractory Multiple Myeloma | Phase 1 | Withdrawn | Roswell Park Cancer Institute | 2026-04-01 | 2026-05-15 | |
| Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Asparaginase Erwinia chrysanthemi, Biospecimen Collection, Bone Marrow Aspiration - B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative, Lymphoblastic Lymphoma | Phase 2 | Recruiting | City of Hope Medical Center | 53 | 2025-10-10 | 2026-10-13 |
| Evaluating Premedication Regimens (Methylprednisolone vs Dexamethasone-based) for the Prevention of Systemic and Injection Site Reactions to Motixafortide in Patients With Multiple Myeloma Undergoing Stem Cell Mobilization, PARADE Trial Acetaminophen, Biospecimen Collection, Dexamethasone - Multiple Myeloma | Phase 4 | Recruiting | Emory University | 94 | 2025-09-24 | 2026-07-23 |
| Epcoritamab Plus Standard of Care Platinum-Based Chemotherapy and Autologous Hematopoietic Cell Transplant for the Treatment of Relapsed or Refractory Large B-cell Lymphoma Autologous Hematopoietic Stem Cell Transplantation, Carboplatin, Cytarabine - Recurrent Diffuse Large B-Cell Lymphoma, Recurrent Diffuse Large B-Cell Lymphoma, Not Otherwise Specified | Phase 2 | Recruiting | University of California, Davis | 25 | 2025-07-31 | 2026-06-30 |
| Testing the Addition of the Anti-cancer Drug Venetoclax and/or the Anti-cancer Immunotherapy Blinatumomab to the Usual Chemotherapy Treatment for Infants With Newly Diagnosed KMT2A-rearranged or KMT2A-non-rearranged Leukemia Asparaginase Erwinia chrysanthemi, Biospecimen Collection, Blinatumomab - Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia | Phase 2 | Recruiting | National Cancer Institute (NCI) | 153 | 2025-06-05 | 2026-10-21 |
| Adding the Immunotherapy Drug Cemiplimab to Usual Treatment for People With Advanced Non-Small Cell Lung Cancer Who Had Previous Treatment With Platinum Chemotherapy and Immunotherapy (An Expanded Lung-MAP Treatment Trial) Biospecimen Collection, Cemiplimab, Computed Tomography - Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 | Phase 2 / Phase 3 | Recruiting | SWOG Cancer Research Network | 378 | 2025-05-22 | 2026-10-09 |
| Elotuzumab, Daratumumab, Iberdomide, and Dexamethasone for the Treatment of Relapsed Multiple Myeloma Bone Marrow Aspiration, Bone Marrow Biopsy, Bone Scan - Recurrent Multiple Myeloma | Phase 1 / Phase 2 | Recruiting | Mayo Clinic | 37 | 2025-03-18 | 2026-06-25 |
| Post-Operative Dosing of Dexamethasone in Patients With Brain Tumors After a Craniotomy, PODS Trial Biospecimen Collection, Computed Tomography, Dexamethasone - Low Grade Glioma, Malignant Brain Glioma | Phase 2 | Recruiting | Emory University | 200 | 2025-01-09 | 2026-02-10 |
| Dexamethasone and Azeliragon for Management of Post-Resection Cerebral Edema in Patients with Glioblastoma Azeliragon, Biospecimen Collection, Computed Tomography - Glioblastoma, Malignant Glioma | Phase 1 | Withdrawn | City of Hope Medical Center | 2024-11-15 | 2024-09-19 | |
| Adding Targeted Drugs to Usual Chemotherapy for Adults With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LBL) Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - T Acute Lymphoblastic Leukemia, T Lymphoblastic Lymphoma | Phase 2 | Withdrawn | National Cancer Institute (NCI) | 2024-08-09 | 2024-05-17 | |
| Comparing the Combination of Selinexor-Daratumumab-Velcade-Dexamethasone (Dara-SVD) With the Usual Treatment (Dara-RVD) for High-Risk Newly Diagnosed Multiple Myeloma Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Multiple Myeloma | Phase 2 | Active not recruiting | National Cancer Institute (NCI) | 58 | 2024-07-23 | 2026-09-25 |
| Comparing Dara-VCD Chemotherapy Plus Stem Cell Transplant to Dara-VCD Chemotherapy Alone for People Who Have Newly Diagnosed AL Amyloidosis Autologous Hematopoietic Stem Cell Transplantation, Biopsy, Biospecimen Collection - AL Amyloidosis | Phase 3 | Recruiting | SWOG Cancer Research Network | 338 | 2024-07-01 | 2026-05-06 |
Showing 20 of 153. Sign in to see all of them.
Multiple Myeloma (57) · Burkitt Lymphoma (25) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (22) · Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (11) · Leukemia, Biphenotypic, Acute (7) · Lymphoma, Mantle-Cell (6) · Immunoglobulin Light-chain Amyloidosis (5) · Lymphoma, Large B-Cell, Diffuse (4) · Precursor B-Cell Lymphoblastic Leukemia-Lymphoma (4) · Smoldering Multiple Myeloma (4) · Blast Crisis (3) · Brain Neoplasms (3) · Carcinoma, Non-Small-Cell Lung (3) · Down Syndrome (3) · Hodgkin Disease (3)
National Cancer Institute (NCI) (31) · M.D. Anderson Cancer Center (30) · Mayo Clinic (25) · Children's Oncology Group (11) · SWOG Cancer Research Network (8) · City of Hope Medical Center (7) · Emory University (7) · ECOG-ACRIN Cancer Research Group (4) · OHSU Knight Cancer Institute (4) · Barbara Ann Karmanos Cancer Institute (3) · Roswell Park Cancer Institute (3) · University of Southern California (3) · University of Washington (3) · Abdullah Khan (2) · Academic and Community Cancer Research United (2)
United States (142) · Canada (19) · Puerto Rico (18) · Australia (17) · New Zealand (14) · Switzerland (7) · Israel (4) · Saudi Arabia (3) · Ireland (2) · Austria (1) · Belgium (1) · Chile (1) · Czechia (1) · Finland (1) · France (1)
Elias Jabbour (7) · Shaji Kumar (5) · Shaji Kumar, M.D. (4) · Farhad Ravandi-Kashani (3) · Sikander Ailawadhi, M.D. (3) · Abdullah M Khan, MBBS, MSc (2) · Anne L Angiolillo (2) · Ibrahim Aldoss (2) · Jana L Portnow (2) · Michael A Rosenzweig (2) · Shaji K Kumar (2) · Shaji K. Kumar, M.D. (2) · Shaji K. Kumar, MD (2) · Sikander Ailawadhi (2)
PMID 35622074, PMID 37890117, PMID 39121442, PMID 41671463, PMID 26590194, PMID 29284596, PMID 36603187, PMID 38446568, PMID 39321347, PMID 40315406, PMID 42085640, PMID 19853510, PMID 20466853, PMID 21860025, PMID 22689675, PMID 23422747, PMID 23678006, PMID 24970932, PMID 25311218, PMID 25964296, PMID 26124497, PMID 26265699, PMID 26432046, PMID 26943915, PMID 27702799, PMID 28017406, PMID 28586789, PMID 28850681, PMID 29296710, PMID 29618479, PMID 29785709, PMID 29812996, PMID 30138085, PMID 30262659, PMID 30501869, PMID 30626253, PMID 32299820, PMID 32414848, PMID 32496902, PMID 32552472, PMID 32589970, PMID 32589978, PMID 32813610, PMID 32866432, PMID 33191168, PMID 33242441, PMID 33357482, PMID 33411585, PMID 33496745, PMID 33512412
U10CA180886 (16), U10CA098543 (13), U10CA180820 (11), U10CA180888 (11), P30CA015083 (9), P30CA138292 (7), P30CA016672 (5), P30CA033572 (5), U10CA021115 (4), U10CA032102 (4), P30CA014089 (3), P30CA022453 (3), P30CA069533 (3), P30CA015704 (2), P30CA093373 (2)